My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 719

    1.

    Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.

    Tikkanen MJ, Laakso M, Ilmonen M, Helve E, Kaarsalo E, Kilkki E, Saltevo J.

    Diabetes Care. 1998 Apr;21(4):477-81.PMID: 9571327 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.

    Sweany AE, Shapiro DR, Tate AC, Goldberg RB, Stein EA.

    Clin Ther. 1995 Mar-Apr;17(2):186-203.PMID: 7614520 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparison between duration dependent effects of Simvastatin and Gemfibrozil on dyslipidemia in patients with type 2 diabetes.

    Ashraf R, Amir K, Shaikh AR.

    J Pak Med Assoc. 2005 Aug;55(8):324-7.PMID: 16164158 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.

    Bruckert E, De Gennes JL, Malbecq W, Baigts F.

    Clin Cardiol. 1995 Nov;18(11):621-9.PMID: 8590530 [PubMed - indexed for MEDLINE]Related articles

    5.

    Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.

    Ose L, Davidson MH, Stein EA, Kastelein JJ, Scott RS, Hunninghake DB, Campodonico S, Insull W, Escobar ID, Schrott HG, Stepanavage ME, Wu M, Tate AC, Melino MR, Mercuri M, Mitchel YB.

    Clin Cardiol. 2000 Jan;23(1):39-46.PMID: 10680028 [PubMed - indexed for MEDLINE]Related articles

    6.

    A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia.

    Bell DS.

    Clin Ther. 1995 Sep-Oct;17(5):901-10.PMID: 8595642 [PubMed - indexed for MEDLINE]Related articles

    7.

    Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.

    Molcányiová A, Stancáková A, Javorský M, Tkác I.

    Pharmacol Res. 2006 Sep;54(3):203-7. Epub 2006 May 4.PMID: 16737822 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.

    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.

    Kardiol Pol. 2004 Jun;60(6):567-77. English, Polish. PMID: 15334157 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Hyperlipidemia in Diabetes Investigators.

    Vinik AI, Colwell JA.

    Diabetes Care. 1993 Jan;16(1):37-44.PMID: 8422814 [PubMed - indexed for MEDLINE]Related articles

    10.

    A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.

    Olsson AG, Eriksson M, Johnson O, Kjellström T, Lanke J, Larsen ML, Pedersen T, Tikkanen MJ, Wiklund O; 3T Study Investigators.

    Clin Ther. 2003 Jan;25(1):119-38.PMID: 12637115 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intensive lipid-lowering strategy in patients with diabetes mellitus.

    Kanters SD, Algra A, de Bruint TW, Erkelens DW, Banga JD.

    Diabet Med. 1999 Jun;16(6):500-8.PMID: 10391399 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.

    Hunninghake DB, Ballantyne CM, Maccubbin DL, Shah AK, Gumbiner B, Mitchel YB.

    Clin Ther. 2003 Jun;25(6):1670-86.PMID: 12860491 [PubMed - indexed for MEDLINE]Related articles

    13.

    Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.

    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.

    Adv Perit Dial. 1996;12:261-5.PMID: 8865916 [PubMed - indexed for MEDLINE]Related articles

    14.

    Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.

    Aguilar-Salinas CA, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores EA, González-Valdez H, Gómez Pérez FJ.

    Metabolism. 2001 Jun;50(6):729-33.PMID: 11398153 [PubMed - indexed for MEDLINE]Related articles

    15.

    A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.

    Nestel P, Simons L, Barter P, Clifton P, Colquhoun D, Hamilton-Craig I, Sikaris K, Sullivan D.

    Atherosclerosis. 1997 Mar 21;129(2):231-9.PMID: 9105566 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide]

    Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L.

    Cardiologia. 1990 Apr;35(4):335-40. Italian. PMID: 2245435 [PubMed - indexed for MEDLINE]Related articles

    17.

    Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus.

    Krempf M, Berthezène F, Wemeau JL, Moinade S, Desriac I, Amelineau E, Passa P.

    Diabetes Metab. 1997 Apr;23(2):131-6.PMID: 9137901 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study.

    Insua A, Massari F, Rodríguez Moncalvo JJ, Rubén Zanchetta J, Insua AM.

    Endocr Pract. 2002 Mar-Apr;8(2):96-101.PMID: 11942772 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Efficacy and safety of simvastatin in patients with hypercholesterolemia (results of a Multicenter Clinical Study)]

    Kukharchuk VV, Bubnova MG, Katel'nitskaia LI, Nikitin IuP, Ol'binskaia LI; Multicenter Clinical Study Participants.

    Kardiologiia. 2003;43(5):42-7. Russian. PMID: 12891239 [PubMed - indexed for MEDLINE]Related articles

    20.

    A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.

    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR; Ezetimibe Study Group.

    Clin Ther. 2004 Nov;26(11):1758-73.PMID: 15639688 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity